We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Roles of Podoplanin in Malignant Progression of Tumor.
- Authors
Suzuki, Hiroyuki; Kaneko, Mika K.; Kato, Yukinari
- Abstract
Podoplanin (PDPN) is a cell-surface mucin-like glycoprotein that plays a critical role in tumor development and normal development of the lung, kidney, and lymphatic vascular systems. PDPN is overexpressed in several tumors and is involved in their malignancy. PDPN induces platelet aggregation through binding to platelet receptor C-type lectin-like receptor 2. Furthermore, PDPN modulates signal transductions that regulate cell proliferation, differentiation, migration, invasion, epithelial-to-mesenchymal transition, and stemness, all of which are crucial for the malignant progression of tumor. In the tumor microenvironment (TME), PDPN expression is upregulated in the tumor stroma, including cancer-associated fibroblasts (CAFs) and immune cells. CAFs play significant roles in the extracellular matrix remodeling and the development of immunosuppressive TME. Additionally, PDPN functions as a co-inhibitory molecule on T cells, indicating its involvement with immune evasion. In this review, we describe the mechanistic basis and diverse roles of PDPN in the malignant progression of tumors and discuss the possibility of the clinical application of PDPN-targeted cancer therapy, including cancer-specific monoclonal antibodies, and chimeric antigen receptor T technologies.
- Subjects
CANCER invasiveness; CARDIOVASCULAR system; CHIMERIC antigen receptors; EXTRACELLULAR matrix; LUNG development
- Publication
Cells (2073-4409), 2022, Vol 11, Issue 3, p575
- ISSN
2073-4409
- Publication type
Article
- DOI
10.3390/cells11030575